MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$35,000K
Net Income
$27,901K
Net Profit Margin
79.72%
EPS
$0.89
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
35,000
-
-45*
90
Research and development, net of reimbursements
5,377
4,201
7,434*
4,248
General and administrative
2,058
1,702
8,976*
1,534
Total operating expenses
7,435
5,903
16,409*
5,782
Income/(loss) from operations
27,565
-5,903
-16,454*
-5,692
Interest income - net
336
381
581
561
Total other income
336
381
581*
561
Income/(loss) before income taxes
27,901
-
-
-
Net income/(loss)
27,901
-5,522
-15,873
-5,131
Basic EPS
0.89
-0.18
-0.509
-0.16
Diluted EPS
0.89
-0.18
-0.509
-0.16
Basic Average Shares
31,399,086
31,237,681
31,195,891
31,195,891
Diluted Average Shares
31,406,740
31,237,681
31,195,891
31,195,891
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total revenue
$35,000K
Interest income - net
$336K
(-46.24%↓ Y/Y)
Income/(loss) from operations
$27,565K
(467.39%↑ Y/Y)
Total other income
$336K
(-46.24%↓ Y/Y)
Total operating
expenses
$7,435K
(-0.91%↓ Y/Y)
Income/(loss) before income
taxes
$27,901K
Research and
development, net of...
$5,377K
(10.21%↑ Y/Y)
General and
administrative
$2,058K
(-21.57%↓ Y/Y)
Net income/(loss)
$27,901K
(505.66%↑ Y/Y)
Buy us a coffee
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (ATNM)